The stigma of having alopecia causes more depression and anxiety than the disease itself, new research has found.

The stigma of having alopecia causes more depression and anxiety than the disease itself, new research has found.

Leqselvi (deuruxolitinib) 8 mg tablets are approved for adults with severe alopecia areata, a disease that causes the immune system to attack hair follicles, leading to partial or complete hair loss ...

After resolving a patent dispute with Incyte, Sun Pharma has officially launched its JAK inhibitor Leqselvi in the U.S. | Sun ...

When I was dealing with postpartum hair loss, I remember wishing there was something beyond biotin gummies and hope to help those rogue baby hairs grow faster. These days, the best red-light therapy ...

Abbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. AbbVie is conducting a Phase 3 clinical study ...

Actor Anthony Carrigan opened up to "Good Morning America" about his deeply personal connection to his "Superman" role.

Eli Lilly LLY and partner Incyte INCY announced that a late-stage study evaluating oral baricitinib in adolescent patients (aged 12-18) with severe alopecia areata (AA) showed clinically ...

Prior to Olumiant, no drug was specifically approved by the FDA for alopecia areata. The traditional treatment has been monthly steroid injections.

A new drug that has gotten FDA approval may provide some relief for adults battling alopecia areata. As reported by […] The post Drug to treat alopecia gets FDA approval appeared first on TheGrio.

The FDA has approved Olumiant (baricitinib) as a treatment for alopecia areata hair loss following two randomized, double-blind, placebo-controlled trials.